CCKBR and medullary thyroid gland carcinoma: Given the rarity of a disease such as MTC, the widespread availability of the radiopharmaceutical is a key factor in simplifying the implementation of the evaluation of the CCK2R expression status in patients by PET/CT imaging also in other institutes.